Biotech Buzz: Leerink Partners Bets Big on Monopar's Future

A Glimmer of Hope: Investigating a Dual-Impact Drug for Parkinsonian Syndromes

The Bidding Blitz: Why Novo Nordisk's Loss to Pfizer Isn't Just About Money

AstraZeneca's Quiet Triumph: A Deeper Dive into Q3's Surprising Win

The Billion-Dollar Battle for a Breakthrough: Pfizer's Big Bet on Oral Obesity Drugs

The Race for a Breakthrough: Pfizer's Bold Bet on Battling Obesity, Outmaneuvering Novo Nordisk

The Weight of Ambition: Pfizer’s Bold Move into the Obesity Race

The Prize Fight for Progress: Pfizer Snags Metacrine in a High-Stakes Metabolic Drug Scramble

The Battle for the Next Blockbuster: Pfizer Steps Up in the Obesity Drug Wars

The $11.6 Billion Bet: Pfizer Jumps Headfirst into the Weight Loss Race

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great Weigh-In: Pfizer's Bold Bet in the Billion-Dollar Battle for Obesity Drug Dominance

Florida's Arthritis Patients Face a Looming Threat: Is Washington's Drug Pricing Plan Stifling the Hope for New Cures?

The $10 Billion Gamble: Pfizer's Bold Leap into the Weight-Loss Frontier

The Quiet Roar of Progress: Unpacking Silence Therapeutics' Latest Chapter

A Whisper of Hope for Weary Lungs: Rein Therapeutics Unveils a Game-Changer?

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

The Shifting Sands of Scalp Science: Biotech's Bold Bet on Regrowing What We've Lost

The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp

Rewriting the Rules: How Tiny Molecules Are Unlocking a Giant Future for Medicine

Hope on the Horizon: Vera Therapeutics Charts a Course Through Critical Clinical Milestones

The Great Drug Price Tug-of-War: Democrats Target a Rare Loophole

High Stakes & Shifting Sands: Inside Pharma's Latest Power Plays in Cancer and Autoimmune Disease

The Biotech Crucible: Weighing the Risks and Rewards of Morphosys and Calithera Biosciences

The Shifting Sands of Cancer Treatment: Why One Firm Sees Revolution Medicines as a Game Changer

The Lab That Thinks for Itself: Inside BU’s Race to Automate Discovery with AI

The Biotech Bet: Sensei Biotherapeutics Halts a Promising Drug, Seeking a New Path Forward

The Great Biotech Reckoning: Moderna's Wild Ride from Pandemic Hero to Post-COVID Crossroads

A Tremor of Hope: Tectonic Surges Unveils Early Data in the Battle Against Pulmonary Hypertension

The Biologic Revolution: Unpacking the Promise and Price of Tomorrow's Cures

The Unfolding Story of Hope: BridgeBio's Double Victory in the Battle Against Rare Disease

A Shot in the Arm for Purple Biotech: Unpacking the Hype Around a Promising Cancer Drug

Biotech's Pulse Check: AI Rises, a Cancer Test Stumbles, and a Rare Disease Shines

A Glimmer of Hope: Anavex's Alzheimer's Drug Shows Enduring Promise

The $8.9 Billion Bet: Thermo Fisher's Bold Play to Redefine Clinical Trials

The Unseen Pulse: How Cytokinetics is Quietly Reshaping the Future of Heart Health

The Grand Alliance: Eli Lilly, NVIDIA, and the Supercomputer Set to Reshape Medicine

The Shifting Sands of Pharma: Why India's CDMOs Face a Defining Moment of Specialization

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets